Swayampakula Ramakanth Profile - H.C. Wainwright Analyst

2,419 Followers
tipranks
Swayampakula Ramakanth

Swayampakula Ramakanth
H.C. Wainwright

Wall Street Analyst
#8,501 out of 8,580 Wall Street Analysts
#35,164 out of 35,568 experts

Success Rate

20%
100 out of 501 ratings made a profit

Average Return

-27.00%
Average return per rating
Time Frame
1 Year
Compare to
No Benchmark
Copying Swayampakula Ramakanth's trades since 2015 and holding each position for 1 Year would result in 19.96% of your transactions generating a profit, with an average return of -27.0% per rating.

Stock Rating Distribution

2KRatings
93.00% Buy
7.00% Hold
0.00% Sell
Distribution of Swayampakula Ramakanth's ratings

Additional Information

Main Sector:Healthcare
Geo Coverage:
United StatesUS Market
CanadaCanadian Market
FranceFrance Market

Best Rating

Stock:
ImmunoGen
(IMGN)
Rating:Buy
Date:Aug 01, 2022 - Aug 01, 2023
Return:+302.70%
The most profitable rating made by Swayampakula Ramakanth

Swayampakula Ramakanth's Stock Coverage

Company
Date
Position
Action
Price Target
No. of Ratings
Success Rate
Avg. Return
Aldeyra Therapeutics
May 14, 2015
Buy
Reiterated
$14.00
(709.25% Upside)
1Ratings
0.00%
Strata Skin Sciences
Aug 24, 2015
Buy
Reiterated
$5.00
(783.39% Upside)
6Ratings
0.00%
Sorrento Therapeutics
Dec 07, 2015
Buy
Assigned
$45.00
7Ratings
0.00%
XTL Biopharmaceuticals Ltd. Sponsored ADR
Mar 22, 2016
Buy
Reiterated
$6.00
(512.49% Upside)
1Ratings
0.00%
Rebus Holdings
Mar 28, 2016
Buy
Reiterated
$2.00
4Ratings
0.00%
Xtant Medical Holdings
Aug 03, 2016
Buy
Reiterated
5Ratings
0.00%
Imunon
Nov 11, 2016
Buy
Reiterated
$3.00
(197.03% Upside)
3Ratings
0.00%
Capricor Therapeutics
Nov 16, 2016
Buy
Reiterated
2Ratings
0.00%
Kazia Therapeutics
Feb 28, 2017
Buy
Reiterated
$20.00
(3073.60% Upside)
5Ratings
0.00%
Immutep
Feb 28, 2017
Buy
Reiterated
$7.50
(318.99% Upside)
4Ratings
0.00%
List of latest recommendations made by Swayampakula Ramakanth. Click to expand and see Swayampakula Ramakanth's performance on a particular stock
Disclaimer: TipRanks collects analysts’ ratings and price targets by scanning publicly available reports on financial websites and by receiving reports from analysts, firms, or customers. The information and statistics displayed might not be accurate, complete, or up-to-date. The analyst ratings provided are the sole responsibility of the source publication. TipRanks holds no liability over the analysts' information, price targets, ratings, or opinions expressed.
Send Us Reports
If you receive reports that you think we are missing, we will thank you with a free Ultimate upgrade!
Learn More >

Swayampakula Ramakanth activity FAQ

What is the performance of Swayampakula Ramakanth's recommendations?
The percentage of profitable recommendations made by Swayampakula Ramakanth is 20%, and the average return per transaction is -27.00%.
    What stocks does Swayampakula Ramakanth cover?
    Swayampakula Ramakanth mostly covers EDAP , OCGN , CDXS stocks.
      What was Swayampakula Ramakanth’s latest rating?
      Swayampakula Ramakanth latest rating was a hold on RGTPQ with a price target of ―, which represents an Upside of ―
        What was Swayampakula Ramakanth's most profitable rating?
        Swayampakula Ramakanth’s most profitable ratings was a buy on IMGN stock on Aug 01, 2022 - Aug 01, 2023. The return on the trade was +302.70%.
          Where can I see a list of stock analyst ratings?
          You can see a list of daily stock analyst ratings here.
            What are the most recommended stocks by analysts?
            You can see a list of the most recommended stocks by analysts here